HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inmaculada Galindo Selected Research

Infections

1/2023Elucidation of the Cellular Interactome of African Swine Fever Virus Fusion Proteins and Identification of Potential Therapeutic Targets.
1/2023N'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile.
1/2023Insights into the function of ESCRT complex and LBPA in ASFV infection.
3/2022Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function.
1/2022New insights into the role of endosomal proteins for African swine fever virus infection.
10/2021Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target.
1/2020African Swine Fever Virus Ubiquitin-Conjugating Enzyme Interacts With Host Translation Machinery to Regulate the Host Protein Synthesis.
1/2019Lipid Exchange Factors at Membrane Contact Sites in African Swine Fever Virus Infection.
1/2018Rigid amphipathic fusion inhibitors demonstrate antiviral activity against African swine fever virus.
10/2017African Swine Fever Virus: A Review.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inmaculada Galindo Research Topics

Disease

19Infections
01/2023 - 01/2004
6African Swine Fever
01/2022 - 02/2012
3Virus Diseases (Viral Diseases)
03/2022 - 02/2012
2Fever (Fevers)
10/2017 - 04/2015
1Ebola Hemorrhagic Fever
01/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2012
1Neoplasms (Cancer)
01/2012
1Ischemia
01/2012
1Acute Kidney Injury (Acute Renal Failure)
01/2012
1Leishmaniasis
05/2010
1Hepatitis E
10/2009
1Coma (Comas)
08/2003
1Ischemic Stroke
08/2003

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2023 - 10/2009
5CholesterolIBA
01/2023 - 02/2012
4Antiviral Agents (Antivirals)IBA
03/2022 - 01/2016
3AntibodiesIBA
01/2012 - 10/2009
2carbazoleIBA
01/2023 - 10/2021
2DNA (Deoxyribonucleic Acid)IBA
03/2022 - 04/2015
2LipidsIBA
01/2019 - 01/2016
2VaccinesIBA
10/2017 - 01/2012
2Phosphatidylinositols (Phosphatidylinositol)IBA
04/2013 - 01/2012
2GTP Phosphohydrolases (GTPases)IBA
02/2012 - 01/2012
1Endosomal Sorting Complexes Required for TransportIBA
01/2023
1Small Interfering RNA (siRNA)IBA
01/2023
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2023
1BenzimidazolesIBA
03/2022
1Nucleic AcidsIBA
01/2022
1Sulfides (Thioethers)IBA
10/2021
1Eukaryotic Initiation Factor-4EIBA
01/2020
1UbiquitinIBA
01/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017
1Ubiquitin-Conjugating EnzymesIBA
01/2017
1Caspase 3 (Caspase-3)IBA
02/2016
1prenylIBA
02/2012
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
02/2012
1Diphosphates (Pyrophosphates)IBA
02/2012
1Capsid Proteins (Capsid Protein)IBA
01/2012
1P-2 (P 2)IBA
01/2012
1FlagellinIBA
01/2012
1phosphatidylinositol 3-phosphateIBA
01/2012
1EnzymesIBA
05/2010
1ImmunosorbentsIBA
05/2010
1Recombinant ProteinsIBA
10/2009
1Peptides (Polypeptides)IBA
10/2009
1AntigensIBA
10/2009
1Genetic Markers (Genetic Marker)IBA
01/2004

Therapy/Procedure

1Therapeutics
05/2010
1Length of Stay
08/2003
1Artificial Respiration (Mechanical Ventilation)
08/2003